These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion. Ray A, LaForge KS, Sehgal PB. Mol Cell Biol; 1990 Nov; 10(11):5736-46. PubMed ID: 2233715 [Abstract] [Full Text] [Related]
5. Cellular factors binding to a novel cis-acting element mediate steroid hormone responsiveness of mouse mammary tumor virus promoter. Lee KI, Reddy EP, Reddy CD. J Biol Chem; 1995 Oct 13; 270(41):24502-8. PubMed ID: 7592667 [Abstract] [Full Text] [Related]
6. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein. Maiyar AC, Phu PT, Huang AJ, Firestone GL. Mol Endocrinol; 1997 Mar 13; 11(3):312-29. PubMed ID: 9058378 [Abstract] [Full Text] [Related]
8. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS. Mol Cell Biol; 1995 Feb 13; 15(2):943-53. PubMed ID: 7823959 [Abstract] [Full Text] [Related]
10. Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences. Vacca A, Martinotti S, Screpanti I, Maroder M, Felli MP, Farina AR, Gismondi A, Santoni A, Frati L, Gulino A. J Biol Chem; 1990 May 15; 265(14):8075-80. PubMed ID: 2159467 [Abstract] [Full Text] [Related]
12. Hormone-independent repression of AP-1-inducible collagenase promoter activity by glucocorticoid receptors. Liu W, Hillmann AG, Harmon JM. Mol Cell Biol; 1995 Feb 15; 15(2):1005-13. PubMed ID: 7823916 [Abstract] [Full Text] [Related]
13. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Pearce D, Yamamoto KR. Science; 1993 Feb 19; 259(5098):1161-5. PubMed ID: 8382376 [Abstract] [Full Text] [Related]
14. Two point mutations in the hormone-binding domain of the mouse glucocorticoid receptor that dramatically reduce its function. Byravan S, Milhon J, Rabindran SK, Olinger B, Garabedian MJ, Danielsen M, Stallcup MR. Mol Endocrinol; 1991 Jun 19; 5(6):752-8. PubMed ID: 1922094 [Abstract] [Full Text] [Related]
17. Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants. de Lange P, Koper JW, Huizenga NA, Brinkmann AO, de Jong FH, Karl M, Chrousos GP, Lamberts SW. Mol Endocrinol; 1997 Jul 19; 11(8):1156-64. PubMed ID: 9212062 [Abstract] [Full Text] [Related]
19. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Santhanam U, Ray A, Sehgal PB. Proc Natl Acad Sci U S A; 1991 Sep 01; 88(17):7605-9. PubMed ID: 1652755 [Abstract] [Full Text] [Related]